 | • レポートコード：D0GIR-05427 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、B型肝炎ワクチン（組換え）の世界市場を広く調査・分析し、今後の市場展望をまとめております。B型肝炎ワクチン（組換え）の種類別市場規模（10mcg/0.5ml、10mcg/ml）、用途別市場規模（新生児、大人）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：GSK、Serum Institute、Dynavax Technologies、Merck、Shenzhen Kangtai Biological Products、Sanofi Pasteur、KM Biologics、LG Life Sciences ・地域別グローバル市場分析 2015年-2020年 ・B型肝炎ワクチン（組換え）の北米市場（アメリカ、カナダ、メキシコ） ・B型肝炎ワクチン（組換え）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・B型肝炎ワクチン（組換え）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・B型肝炎ワクチン（組換え）の南米市場（ブラジル、アルゼンチン） ・B型肝炎ワクチン（組換え）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：10mcg/0.5ml、10mcg/ml ・用途別分析：新生児、大人 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Hepatitis B Vaccine (Recombinant) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Hepatitis B Vaccine (Recombinant) sales will be xx in 2020 from Hepatitis B Vaccine (Recombinant) million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Hepatitis B Vaccine (Recombinant) market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Hepatitis B Vaccine (Recombinant) industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Hepatitis B Vaccine (Recombinant) and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Hepatitis B Vaccine (Recombinant) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Hepatitis B Vaccine (Recombinant) market has been segmented into
10mcg/0.5ml
10mcg/ml
By Application, Hepatitis B Vaccine (Recombinant) has been segmented into:
Newborn
Adult
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Hepatitis B Vaccine (Recombinant) market presented in the report. This section sheds light on the sales growth of different regional and country-level Hepatitis B Vaccine (Recombinant) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Hepatitis B Vaccine (Recombinant) market.
The report offers in-depth assessment of the growth and other aspects of the Hepatitis B Vaccine (Recombinant) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Hepatitis B Vaccine (Recombinant) Market Share Analysis
Hepatitis B Vaccine (Recombinant) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Hepatitis B Vaccine (Recombinant) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Hepatitis B Vaccine (Recombinant) sales, revenue and market share for each player covered in this report.
The major players covered in Hepatitis B Vaccine (Recombinant) are:
GSK
Serum Institute
Dynavax Technologies
Merck
Shenzhen Kangtai Biological Products
Sanofi Pasteur
KM Biologics
LG Life Sciences
Among other players domestic and global, Hepatitis B Vaccine (Recombinant) market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hepatitis B Vaccine (Recombinant) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hepatitis B Vaccine (Recombinant), with price, sales, revenue and global market share of Hepatitis B Vaccine (Recombinant) in 2018 and 2019.
Chapter 3, the Hepatitis B Vaccine (Recombinant) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hepatitis B Vaccine (Recombinant) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Hepatitis B Vaccine (Recombinant) market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Hepatitis B Vaccine (Recombinant) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Hepatitis B Vaccine (Recombinant) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hepatitis B Vaccine (Recombinant) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 10mcg/0.5ml
1.2.3 10mcg/ml
1.3 Market Analysis by Application
1.3.1 Overview: Global Hepatitis B Vaccine (Recombinant) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Newborn
1.3.3 Adult
1.4 Overview of Global Hepatitis B Vaccine (Recombinant) Market
1.4.1 Global Hepatitis B Vaccine (Recombinant) Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Hepatitis B Vaccine (Recombinant) Industry Impact
1.6.1 COVID-19 Potential Implications for the Hepatitis B Vaccine (Recombinant)
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Hepatitis B Vaccine (Recombinant)
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Serum Institute
2.2.1 Serum Institute Details
2.2.2 Serum Institute Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Serum Institute SWOT Analysis
2.2.4 Serum Institute Product and Services
2.2.5 Serum Institute Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Dynavax Technologies
2.3.1 Dynavax Technologies Details
2.3.2 Dynavax Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Dynavax Technologies SWOT Analysis
2.3.4 Dynavax Technologies Product and Services
2.3.5 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Shenzhen Kangtai Biological Products
2.5.1 Shenzhen Kangtai Biological Products Details
2.5.2 Shenzhen Kangtai Biological Products Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Shenzhen Kangtai Biological Products SWOT Analysis
2.5.4 Shenzhen Kangtai Biological Products Product and Services
2.5.5 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi Pasteur
2.6.1 Sanofi Pasteur Details
2.6.2 Sanofi Pasteur Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sanofi Pasteur SWOT Analysis
2.6.4 Sanofi Pasteur Product and Services
2.6.5 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 KM Biologics
2.7.1 KM Biologics Details
2.7.2 KM Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 KM Biologics SWOT Analysis
2.7.4 KM Biologics Product and Services
2.7.5 KM Biologics Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 LG Life Sciences
2.8.1 LG Life Sciences Details
2.8.2 LG Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 LG Life Sciences SWOT Analysis
2.8.4 LG Life Sciences Product and Services
2.8.5 LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Hepatitis B Vaccine (Recombinant) Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Hepatitis B Vaccine (Recombinant) Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Hepatitis B Vaccine (Recombinant) Manufacturer Market Share in 2019
3.3.2 Top 6 Hepatitis B Vaccine (Recombinant) Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Hepatitis B Vaccine (Recombinant) Sales, Revenue and Market Share by Regions
4.1.1 Global Hepatitis B Vaccine (Recombinant) Sales and Market Share by Regions (2015-2020)
4.1.2 Global Hepatitis B Vaccine (Recombinant) Revenue and Market Share by Regions (2015-2020)
4.2 North America Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
4.3 Europe Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
4.5 South America Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Hepatitis B Vaccine (Recombinant) Sales, Revenue and Market Share by Country
5.1.1 North America Hepatitis B Vaccine (Recombinant) Sales and Market Share by Country (2015-2020)
5.1.2 North America Hepatitis B Vaccine (Recombinant) Revenue and Market Share by Country (2015-2020)
5.2 United States Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
5.3 Canada Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
5.4 Mexico Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Hepatitis B Vaccine (Recombinant) Sales, Revenue and Market Share by Country
6.1.1 Europe Hepatitis B Vaccine (Recombinant) Sales and Market Share by Country (2015-2020)
6.1.2 Europe Hepatitis B Vaccine (Recombinant) Revenue and Market Share by Country (2015-2020)
6.2 Germany Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
6.3 UK Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
6.4 France Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
6.5 Russia Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
6.6 Italy Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Hepatitis B Vaccine (Recombinant) Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Hepatitis B Vaccine (Recombinant) Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Hepatitis B Vaccine (Recombinant) Revenue and Market Share by Regions (2015-2020)
7.2 China Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
7.3 Japan Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
7.4 Korea Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
7.5 India Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
7.7 Australia Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Hepatitis B Vaccine (Recombinant) Sales, Revenue and Market Share by Country
8.1.1 South America Hepatitis B Vaccine (Recombinant) Sales and Market Share by Country (2015-2020)
8.1.2 South America Hepatitis B Vaccine (Recombinant) Revenue and Market Share by Country (2015-2020)
8.2 Brazil Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
8.3 Argentina Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
9.3 Turkey Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
9.4 Egypt Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
9.5 South Africa Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Hepatitis B Vaccine (Recombinant) Sales and Market Share by Type (2015-2020)
10.2 Global Hepatitis B Vaccine (Recombinant) Revenue and Market Share by Type (2015-2020)
10.3 Global Hepatitis B Vaccine (Recombinant) Price by Type (2015-2020)
11 Global Hepatitis B Vaccine (Recombinant) Market Segment by Application
11.1 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2015-2020)
11.2 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Application (2015-2020)
11.3 Global Hepatitis B Vaccine (Recombinant) Price by Application (2015-2020)
12 Market Forecast
12.1 Global Hepatitis B Vaccine (Recombinant) Sales, Revenue and Growth Rate (2021-2025)
12.2 Hepatitis B Vaccine (Recombinant) Market Forecast by Regions (2021-2025)
12.2.1 North America Hepatitis B Vaccine (Recombinant) Market Forecast (2021-2025)
12.2.2 Europe Hepatitis B Vaccine (Recombinant) Market Forecast (2021-2025)
12.2.3 Asia-Pacific Hepatitis B Vaccine (Recombinant) Market Forecast (2021-2025)
12.2.4 South America Hepatitis B Vaccine (Recombinant) Market Forecast (2021-2025)
12.2.5 Middle East & Africa Hepatitis B Vaccine (Recombinant) Market Forecast (2021-2025)
12.3 Hepatitis B Vaccine (Recombinant) Market Forecast by Type (2021-2025)
12.3.1 Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Type (2021-2025)
12.3.2 Global Hepatitis B Vaccine (Recombinant) Market Share Forecast by Type (2021-2025)
12.4 Hepatitis B Vaccine (Recombinant) Market Forecast by Application (2021-2025)
12.4.1 Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Application (2021-2025)
12.4.2 Global Hepatitis B Vaccine (Recombinant) Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Hepatitis B Vaccine (Recombinant) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Hepatitis B Vaccine (Recombinant) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Hepatitis B Vaccine (Recombinant) Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Hepatitis B Vaccine (Recombinant) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Hepatitis B Vaccine (Recombinant) Major Business
Table 10. GSK Hepatitis B Vaccine (Recombinant) Total Revenue (USD Million) (2018-2019)
Table 11. GSK SWOT Analysis
Table 12. GSK Hepatitis B Vaccine (Recombinant) Product and Services
Table 13. GSK Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 15. Serum Institute Hepatitis B Vaccine (Recombinant) Major Business
Table 16. Serum Institute Hepatitis B Vaccine (Recombinant) Total Revenue (USD Million) (2018-2019)
Table 17. Serum Institute SWOT Analysis
Table 18. Serum Institute Hepatitis B Vaccine (Recombinant) Product and Services
Table 19. Serum Institute Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Dynavax Technologies Basic Information, Manufacturing Base and Competitors
Table 21. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Major Business
Table 22. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Total Revenue (USD Million) (2018-2019)
Table 23. Dynavax Technologies SWOT Analysis
Table 24. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product and Services
Table 25. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Merck Basic Information, Manufacturing Base and Competitors
Table 27. Merck Hepatitis B Vaccine (Recombinant) Major Business
Table 28. Merck Hepatitis B Vaccine (Recombinant) Total Revenue (USD Million) (2018-2019)
Table 29. Merck SWOT Analysis
Table 30. Merck Hepatitis B Vaccine (Recombinant) Product and Services
Table 31. Merck Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Shenzhen Kangtai Biological Products Basic Information, Manufacturing Base and Competitors
Table 33. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Major Business
Table 34. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Total Revenue (USD Million) (2018-2019)
Table 35. Shenzhen Kangtai Biological Products SWOT Analysis
Table 36. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product and Services
Table 37. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 39. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Major Business
Table 40. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Total Revenue (USD Million) (2018-2019)
Table 41. Sanofi Pasteur SWOT Analysis
Table 42. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product and Services
Table 43. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 45. KM Biologics Hepatitis B Vaccine (Recombinant) Major Business
Table 46. KM Biologics Hepatitis B Vaccine (Recombinant) Total Revenue (USD Million) (2018-2019)
Table 47. KM Biologics SWOT Analysis
Table 48. KM Biologics Hepatitis B Vaccine (Recombinant) Product and Services
Table 49. KM Biologics Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 51. LG Life Sciences Hepatitis B Vaccine (Recombinant) Major Business
Table 52. LG Life Sciences Hepatitis B Vaccine (Recombinant) Total Revenue (USD Million) (2018-2019)
Table 53. LG Life Sciences SWOT Analysis
Table 54. LG Life Sciences Hepatitis B Vaccine (Recombinant) Product and Services
Table 55. LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Global Hepatitis B Vaccine (Recombinant) Sales by Manufacturer (2018-2019) (K Units)
Table 57. Global Hepatitis B Vaccine (Recombinant) Revenue by Manufacturer (2018-2019) (USD Million)
Table 58. Global Hepatitis B Vaccine (Recombinant) Sales by Regions (2015-2020) (K Units)
Table 59. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Regions (2015-2020)
Table 60. Global Hepatitis B Vaccine (Recombinant) Revenue by Regions (2015-2020) (USD Million)
Table 61. North America Hepatitis B Vaccine (Recombinant) Sales by Countries (2015-2020) (K Units)
Table 62. North America Hepatitis B Vaccine (Recombinant) Sales Market Share by Countries (2015-2020)
Table 63. North America Hepatitis B Vaccine (Recombinant) Revenue by Countries (2015-2020) (USD Million)
Table 64. North America Hepatitis B Vaccine (Recombinant) Revenue Market Share by Countries (2015-2020)
Table 65. Europe Hepatitis B Vaccine (Recombinant) Sales by Countries (2015-2020) (K Units)
Table 66. Europe Hepatitis B Vaccine (Recombinant) Sales Market Share by Countries (2015-2020)
Table 67. Europe Hepatitis B Vaccine (Recombinant) Revenue by Countries (2015-2020) (USD Million)
Table 68. Asia-Pacific Hepatitis B Vaccine (Recombinant) Sales by Regions (2015-2020) (K Units)
Table 69. Asia-Pacific Hepatitis B Vaccine (Recombinant) Sales Market Share by Regions (2015-2020)
Table 70. Asia-Pacific Hepatitis B Vaccine (Recombinant) Revenue by Regions (2015-2020) (USD Million)
Table 71. South America Hepatitis B Vaccine (Recombinant) Sales by Countries (2015-2020) (K Units)
Table 72. South America Hepatitis B Vaccine (Recombinant) Sales Market Share by Countries (2015-2020)
Table 73. South America Hepatitis B Vaccine (Recombinant) Revenue by Countries (2015-2020) (USD Million)
Table 74. South America Hepatitis B Vaccine (Recombinant) Revenue Market Share by Countries (2015-2020)
Table 75. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales by Countries (2015-2020) (K Units)
Table 76. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales Market Share by Countries (2015-2020)
Table 77. Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue by Countries (2015-2020) (USD Million)
Table 78. Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue Market Share by Countries (2015-2020)
Table 79. Global Hepatitis B Vaccine (Recombinant) Sales by Type (2015-2020) (K Units)
Table 80. Global Hepatitis B Vaccine (Recombinant) Sales Share by Type (2015-2020)
Table 81. Global Hepatitis B Vaccine (Recombinant) Revenue by Type (2015-2020) (USD Million)
Table 82. Global Hepatitis B Vaccine (Recombinant) Revenue Share by Type (2015-2020)
Table 83. Global Hepatitis B Vaccine (Recombinant) Sales by Application (2015-2020) (K Units)
Table 84. Global Hepatitis B Vaccine (Recombinant) Sales Share by Application (2015-2020)
Table 85. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Regions (2021-2025) (K Units)
Table 86. Global Hepatitis B Vaccine (Recombinant) Market Share Forecast by Regions (2021-2025)
Table 87. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Type (2021-2025) (K Units)
Table 88. Global Hepatitis B Vaccine (Recombinant) Market Share Forecast by Type (2021-2025)
Table 89. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Application (2021-2025)
Table 90. Global Hepatitis B Vaccine (Recombinant) Market Share Forecast by Application (2021-2025)
Table 91. Direct Channel Pros & Cons
Table 92. Indirect Channel Pros & Cons
Table 93. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Hepatitis B Vaccine (Recombinant) Picture
Figure 2. Global Sales Market Share of Hepatitis B Vaccine (Recombinant) by Type in 2019
Figure 3. 10mcg/0.5ml Picture
Figure 4. 10mcg/ml Picture
Figure 5. Hepatitis B Vaccine (Recombinant) Sales Market Share by Application in 2018
Figure 6. Newborn Picture
Figure 7. Adult Picture
Figure 8. Global Hepatitis B Vaccine (Recombinant) Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Hepatitis B Vaccine (Recombinant) Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Hepatitis B Vaccine (Recombinant) Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Hepatitis B Vaccine (Recombinant) Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Hepatitis B Vaccine (Recombinant) Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Hepatitis B Vaccine (Recombinant) Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Hepatitis B Vaccine (Recombinant) Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Hepatitis B Vaccine (Recombinant) Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Hepatitis B Vaccine (Recombinant) Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Hepatitis B Vaccine (Recombinant) Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Hepatitis B Vaccine (Recombinant) Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Hepatitis B Vaccine (Recombinant) Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Hepatitis B Vaccine (Recombinant) Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Hepatitis B Vaccine (Recombinant) Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Hepatitis B Vaccine (Recombinant) Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Hepatitis B Vaccine (Recombinant) Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Hepatitis B Vaccine (Recombinant) Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Hepatitis B Vaccine (Recombinant) Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Hepatitis B Vaccine (Recombinant) Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Hepatitis B Vaccine (Recombinant) Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Manufacturer in 2019
Figure 29. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Hepatitis B Vaccine (Recombinant) Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Hepatitis B Vaccine (Recombinant) Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Hepatitis B Vaccine (Recombinant) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Regions (2015-2020)
Figure 36. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Regions in 2018
Figure 37. North America Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
Figure 38. Europe Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
Figure 40. South America Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020)
Figure 42. North America Hepatitis B Vaccine (Recombinant) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Hepatitis B Vaccine (Recombinant) Sales Market Share by Countries (2015-2020)
Figure 44. North America Hepatitis B Vaccine (Recombinant) Sales Market Share by Countries in 2018
Figure 45. North America Hepatitis B Vaccine (Recombinant) Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Hepatitis B Vaccine (Recombinant) Revenue Market Share by Countries in 2018
Figure 47. United States Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Hepatitis B Vaccine (Recombinant) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Hepatitis B Vaccine (Recombinant) Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Hepatitis B Vaccine (Recombinant) Revenue Market Share by Countries in 2019
Figure 53. Germany Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Hepatitis B Vaccine (Recombinant) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Hepatitis B Vaccine (Recombinant) Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Hepatitis B Vaccine (Recombinant) Revenue Market Share by Regions 2019
Figure 61. China Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Hepatitis B Vaccine (Recombinant) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Hepatitis B Vaccine (Recombinant) Sales Market Share by Countries in 2019
Figure 68. South America Hepatitis B Vaccine (Recombinant) Revenue Market Share by Countries in 2019
Figure 69. Brazil Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Hepatitis B Vaccine (Recombinant) Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Hepatitis B Vaccine (Recombinant) Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Hepatitis B Vaccine (Recombinant) Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Hepatitis B Vaccine (Recombinant) Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Hepatitis B Vaccine (Recombinant) Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Hepatitis B Vaccine (Recombinant) Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Hepatitis B Vaccine (Recombinant) Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
新型コロナウイルス感染症組換えタンパク質ワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The COVID-19 Recombinant Protein Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chai…- B型肝炎ウイルス（HBV）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Hepatitis B Vir (HBV) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hepatitis B Vir (HBV) m…
- C型肝炎ウイルス（HCV）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Hepatitis C Virus(HCV) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hepatitis C Virus(HCV)…
- 予防B型肝炎ウイルスワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Prophylactic Hepatitis B Virus Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Proph…
- C型肝炎薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Hepatitis C Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hepatitis C Drugs market re…